XML 58 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2024
Stock Settled Stock Appreciation Rights SARS [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our SSSARs compensation expense and tax benefits recorded for each of the years ended June 30:
202420232022
Compensation expense$1,038 $1,972 $3,566 
Tax benefits$90 $216 $749 
Intrinsic value of exercises$677 $3,873 $317 
Fair Value Of Awards Vested
The total fair values of SSSARs vested for each of the years ended June 30 were as follows:
202420232022
Fair value of vested rights$1,175 $2,611 $4,095 
Stock-Settled Stock Appreciation Rights Activity
The following table summarizes the activity relating to SSSARs granted under the plan for the year ended June 30, 2024:
Number of
Rights		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life in
Years		Aggregate
Intrinsic
Value
Outstanding at beginning of year155 $165.77 
Exercised(115)$164.32 
Granted— $— 
Forfeited(1)$177.99 
Outstanding at end of year39 $169.75 3.27$745 
Exercisable and vested at end of year39 $169.75 3.27$745 
Vested and expected to vest at end of year39 $169.75 3.27$745 
Stock-Settled Stock Appreciation Rights Outstanding By Grant Year
The following table summarizes information about the SSSARs outstanding by grant year at June 30, 2024:
 OutstandingExercisable
   Weighted Average  
Grant YearsRange of
Exercise Prices		Number
Outstanding		Remaining
Contractual
Life in
Years		Exercise
Price		Number
Exercisable		Weighted
Average
Exercise
Price
2021
$167.18-$187.30
263.63$177.6626$177.66
2020
$153.71-$154.22
132.54$153.7413$153.74
Employee Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2024, 2023 and 2022, we granted shares of restricted stock to various employees under the terms of the plan. The following table summarizes information relating to these grants:
202420232022
Employees
Restricted stock granted33 29 30 
Grant date fair value$6,076 $4,448 $5,691 
Weighted average grant date fair value per award$185.05 $154.80 $189.12 
Director Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2024, 2023 and 2022, we also granted shares of restricted stock to our nonemployee directors under the terms of the plan. The following table summarizes information relating to each of these grants:
202420232022
Nonemployee directors
Restricted stock granted5 4 5 
Grant date fair value$920 $919 $799 
Weighted average grant date fair value per award$165.41 $203.34 $162.15 
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our restricted stock compensation expense and tax benefits recorded for each of the years ended June 30:
202420232022
Compensation expense$5,479 $4,432 $4,942 
Tax benefits$841 $677 $1,038 
Fair Value Of Awards Vested
The total fair values of restricted stock vested for each of the years ended June 30 were as follows:
202420232022
Fair value of vested shares$3,287 $4,996 $2,772 
Restricted Stock Activity
The following table summarizes the activity relating to restricted stock granted under the plan for the year ended June 30, 2024:
Number of
Shares		Weighted
Average Grant
Date Fair Value
Unvested restricted stock at beginning of year65 $174.62 
Granted38 $182.20 
Vested(18)$181.81 
Forfeited(5)$177.98 
Unvested restricted stock at end of year80 $176.21 
Performance Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2024, 2023 and 2022, we granted performance units to various employees under the terms of the plan. The following table summarizes information relating to these grants:
202420232022
Performance units granted25 26 20 
Grant date fair value$4,745 $4,572 $4,151 
Weighted average grant date fair value per award$192.91 $173.73 $201.67 
Compensation Expense And Tax Benefits Recorded
The following table summarizes our performance units compensation expense and tax benefits recorded for each of the years ended June 30:
202420232022
Compensation expense$4,842 $2,678 $1,055 
Tax benefits$620 $355 $222 
Performance Units Grant Date Valuation Assumptions For our performance units with a market condition, the grant-date fair value is estimated using a Monte Carlo simulation. The assumptions used in the Monte Carlo simulation were as follows:
202420232022
Risk-free interest rate4.60 %3.18 %0.41 %
Dividend yield1.78 %2.08 %1.65 %
Volatility factor of the expected market price of our common stock24.60 %32.20 %31.30 %
Performance Units Activity
The following table summarizes the activity relating to performance units granted under the plan for the year ended June 30, 2024:
Number of
Units		Weighted
Average Grant
Date Fair Value
Unvested performance units at beginning of year40 $185.39 
Granted25 $192.91 
Vested— $— 
Forfeited(3)$186.49 
Unvested performance units at end of year62 $188.34